Stay updated with breaking news from Intas Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits
Our specially curated package of the most interesting articles to help you stay at the top of your game.
On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application (MAA) for DMB-3115, a biosimilar referencing STELARA (ustekinumab)....
Plaintiffs Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc. (Dana Farber) filed a complaint against defendants Accord
In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us 25/05/2021 Representative photo: analuisa gamboa/Unsplash Mumbai: Since the start of the COVID-19 pandemic last year, researchers around the world have evaluated scores of drugs and therapeutic techniques for the disease. Even according to the Clinical Trial Registry of India (CTRI), researchers in the country are testing everything from inhaled camphor and ajwain to Viagra. This may be desperation, given the brutality of India’s second COVID-19 outbreak. It is also worthwhile in more ways than one ...